Deals
Curaleaf Enters Europe Cannabis Market in $285 Million Deal
- Company will pay cash and stock for Emmac Life Sciences
- Emmac CEO calls deal a ‘game-changer’ for global marijuana
Source: Bloomberg Television
This article is for subscribers only.
Curaleaf Holdings Inc. agreed to buy Emmac Life Sciences Ltd. for about $285 million, giving the company entry into Europe’s rapidly growing cannabis market.
“By doing this transaction, Curaleaf is indisputably the largest operator on a revenue and a footprint basis around the globe,” Executive Chairman Boris Jordan said in an interview Tuesday. With a market capitalization about $11 billion, Curaleaf is already the largest U.S.-based multistate operator.